Dallas, TX, United States of America

Juan Bayo-Fina

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juan Bayo-Fina: Innovator in Cancer Treatment

Introduction

Juan Bayo-Fina is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on addressing chemotherapy resistance and radioresistance in cancer patients.

Latest Patents

Juan Bayo-Fina holds a patent for the "Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer." This patent discloses methods for utilizing Jumonji C demethylase inhibitors to radiosensitize cancer cells and to treat and prevent chemotherapy resistance. His innovative approach aims to improve the efficacy of cancer treatments and enhance patient outcomes.

Career Highlights

Juan is affiliated with the University of Texas System, where he conducts his research and develops his inventions. His work has garnered attention for its potential to revolutionize cancer therapy and improve the lives of patients facing treatment challenges.

Collaborations

Juan collaborates with esteemed colleagues, including Maithili P Dalvi and Elisabeth D Martínez. Their combined expertise contributes to the advancement of cancer research and the development of effective treatment strategies.

Conclusion

Juan Bayo-Fina is a pioneering inventor whose work in cancer treatment exemplifies the impact of innovative research on healthcare. His patented methods offer hope for overcoming significant challenges in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…